Boston Scientific said that a U.S. District Court jury in Delaware has found that Johnson & Johnson's Cypher drug-eluting stent infringes a Boston Scientific patent.
The jury also found that Johnson & Johnson's Cypher, Bx Velocity, Bx Sonic, and Genesis stents infringe a second Boston Scientific patent, according to the Natick, MA-based firm.
The jury also upheld the validity of both patents, Boston Scientific said. Money damages and any other relief will be determined at a later date.
By AuntMinnie.com staff writers
July 4, 2005
Related Reading
Jury favors J&J over Boston Scientific on stent patent, June 22, 2005
Boston Scientific ends first enrollment phase of Liberté trial, June 21, 2005
Boston Scientific notches 400th Liberté enrollment, May 26, 2005
Boston Scientific posts strong Q1, April 20, 2005
Boston Scientific gets FDA approval for Liberté stent, April 14, 2005
Copyright © 2005 AuntMinnie.com
